U.S officials on Monday said the first human trial to evaluate a candidate vaccine against coronavirus disease 2019 has begun in Seattle.
The US National institutes of Health in a statement said “The open-label trial will enrol 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks,”.
“The first participant received the investigational vaccine today.”
Latest entries from the author
- Health2020.12.31COVID-19 Vaccine: WHO Grants Emergency Approval For Pfizer-BioNTech
- Health2020.12.29476 Health Workers Contract COVID-19 In Abuja
- Health2020.12.10Sanwo-Olu Approves Free Healthcare For 50,000 Orphans, Elderly, Vulnerable
- News2020.11.26GIFSHIP: FG Launches New Health Insurance Scheme For Nigerians